David Shaw’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-23,500
Closed -$2.71M 4668
2020
Q4
$2.71M Hold
23,500
﹤0.01% 2351
2020
Q3
$2.29M Hold
23,500
﹤0.01% 2309
2020
Q2
$2.88M Hold
23,500
﹤0.01% 2111
2020
Q1
$2.06M Sell
23,500
-15,000
-39% -$1.59M ﹤0.01% 2143
2019
Q4
$4.03M Buy
38,500
+3,600
+10% +$404K ﹤0.01% 1905
2019
Q3
$4.01M Hold
34,900
﹤0.01% 1819
2019
Q2
$6.02M Hold
34,900
0.01% 1468
2019
Q1
$5.88M Sell
34,900
-10,100
-22% -$1.5M 0.01% 1443
2018
Q4
$4.38M Hold
45,000
0.01% 1595
2018
Q3
$7.77M Buy
45,000
+10,000
+29% +$1.44M 0.01% 1266
2018
Q2
$4.88M Buy
35,000
+15,000
+75% +$2.13M 0.01% 1554
2018
Q1
$2.25M Sell
20,000
-66,200
-77% -$8.32M ﹤0.01% 1967
2017
Q4
$11.4M Hold
86,200
0.02% 957
2017
Q3
$8.75M Hold
86,200
0.01% 1027
2017
Q2
$8.64M Hold
86,200
0.01% 984
2017
Q1
$10.4M Sell
86,200
-47,700
-36% -$5.85M 0.02% 863
2016
Q4
$15M Buy
133,900
+40,000
+43% +$4.81M 0.03% 746
2016
Q3
$12.5M Buy
93,900
+26,200
+39% +$2.5M 0.02% 778
2016
Q2
$6.2M Buy
67,700
+20,000
+42% +$1.68M 0.01% 1153
2016
Q1
$3.44M Hold
47,700
0.01% 1526
2015
Q4
$3.31M Buy
47,700
+23,900
+100% +$1.95M ﹤0.01% 1739
2015
Q3
$2.17M Sell
23,800
-2,300
-9% -$256K ﹤0.01% 2039
2015
Q2
$3.21M Buy
26,100
+13,800
+112% +$1.57M ﹤0.01% 1821
2015
Q1
$1.12M Buy
+12,300
New +$999K ﹤0.01% 2481
2014
Q3
Sell
-10,000
Closed -$1.07M 4492
2014
Q2
$1.07M Buy
+10,000
New +$695K ﹤0.01% 2878

Other funds holding GWPH

David Shaw's GWPH Position: Q2 2021 in Review

David Shaw sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 259,796 shares — an estimated $56.4M sold.

David Shaw first reported a position in GWPH in Q2 2014 and held it in 21 quarters. The position peaked at $56.4M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • David Shaw reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • David Shaw sold 259,796 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $56.4M.
  • David Shaw first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2014 and held it in 21 quarters.
  • David Shaw's GW Pharmaceuticals Plc American Depositary Shares position peaked at $56.4M in Q1 2021.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on D.E. Shaw & Co's 13F filing for Q2 2021, filed 16 Aug 2021.